Literature DB >> 97712

Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat.

J L Bloss, G H Singer.   

Abstract

Prostaglandin E2 (PGE2) and 11-thiol-11-desoxy Prostaglandin E2 (SHPGE2) were evaluated in a variety of behavioral and neuropharmacological procedures that are sensitive to neuroleptics. Clozapine (C), thioridazine (T), haloperidol (H), and fluphenazine (F) were also tested for comparison. All agents except T suppressed avoidance responses in trained rats at one or more doses without concurrently disrupting escape behavior. T, H, and F dose-responsively antagonized lesioned rat rotational behavior at nontoxic doses. T, H, and F induced catalepsy at doses considerably higher than those effective on rotational behavior. SHPGE2, PGE2, and C did not cause catalepsy and did not show statistically significant dose-response antagonism of rotational behavior at less than toxic doses. All agents tested blocked d-amphetamine-induced lethality and caused motor incoordination dose-responsively. SHPGE2, PGE2, C, and T caused statistically significant blockade of physostigmine-induced lethality. H and F were ineffective against physostigmine lethality. It was concluded that SHPGE2 and PGE2 demonstrated, qualitatively, a spectrum of neuroleptic like properties remarkably similar to C.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97712     DOI: 10.1007/bf00426754

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.

Authors:  T Honma; H Fukushima
Journal:  Neuropharmacology       Date:  1976-10       Impact factor: 5.250

2.  EFFECTS OF DRUGS ON AVOIDANCE AND ESCAPE BEHAVIOR.

Authors:  L COOK; A C CATANIA
Journal:  Fed Proc       Date:  1964 Jul-Aug

3.  The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.

Authors:  P H Kelly; R J Miller
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

Review 4.  Prostaglandins and the central nervous system.

Authors:  F Coceani
Journal:  Arch Intern Med       Date:  1974-01

5.  Activation of the pathway from locus coeruleus to rat cerebellar Purkinje neurons: pharmacological evidence of noradrenergic central inhibition.

Authors:  B J Hoffer; G R Siggins; A P Oliver; F E Bloom
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

6.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

7.  Functional role of the nigro-neostriatal dopamine neurons.

Authors:  N E Andén; A Dahlström; K Fuxe; K Larsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1966

8.  Effect of prostaglandin E 2 on central and peripheral catecholamine neurons.

Authors:  S Bergström; L O Farnebo; K Fuxe
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

9.  Actions of prostaglandins E1, E2, and F2-alpha on brain stem neurones.

Authors:  G L Avanzino; P B Bradley; J H Wolstencroft
Journal:  Br J Pharmacol Chemother       Date:  1966-05

10.  ACTIONS OF PROSTAGLANDINS E1, E2 AND E3 ON THE CENTRAL NERVOUS SYSTEM.

Authors:  E W HORTON
Journal:  Br J Pharmacol Chemother       Date:  1964-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.